Chapter 24 - CENTRAL REPOSITORY FOR CONTROLLED SUBSTANCES DATA
- Section 25-26-24-1 - "Board"
- Section 25-26-24-2 - "Committee"
- Section 25-26-24-2.5 - "Controlled substance"
- Section 25-26-24-3 - "Dispense"
- Section 25-26-24-4 - "Ephedrine"
- Section 25-26-24-5 - "Exception report"
- Section 25-26-24-6 - "Identification number"
- Section 25-26-24-7 - "INSPECT"
- Section 25-26-24-8 - "Interoperability"
- Section 25-26-24-9 - "Pain management clinic"
- Section 25-26-24-10 - "Patient"
- Section 25-26-24-11 - "Practitioner"
- Section 25-26-24-12 - "Prescription"
- Section 25-26-24-13 - "Pseudoephedrine"
- Section 25-26-24-14 - "Recipient"
- Section 25-26-24-15 - "Recipient representative"
- Section 25-26-24-16 - "State"
- Section 25-26-24-17 - Program components; recommendations; retail pharmacy
- Section 25-26-24-18 - Program requirements; execution of contracts; data; funding
- Section 25-26-24-19 - Confidentiality; disclosure; release of information; applicants; statistical reports; data base; immunity
- Section 25-26-24-19.5 - Release of INSPECT information to a veterinarian
- Section 25-26-24-20 - Certification requirement
- Section 25-26-24-21 - Review by governing board of dissemination of exception reports; investigation
- Section 25-26-24-22 - Rules; standards; intervention and treatment
- Section 25-26-24-23 - Fund
- Section 25-26-24-24 - Committee; members; recommendations; meetings; term
- Section 25-26-24-25 - Violations
- Section 25-26-24-26 - Rules transferred